Drugs acting on the gastrointestinal system

Equine Clinical Pharmacology

Volumn , Issue , 2004, Pages 85-120

  Murray, Michael J ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84942591528     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7020-2484-9.50010-9     Document Type: Chapter

References (144)

1. Adams SB, MacHarg MA Neostigmine methylsulfate delays gastric emptying of particulate markers in horses. American Journal of Veterinary Research 1985, 46:2498-2499.
2. Adams SB, Lamar CH, Masty J Motility of the distal portion of the jejunum and pelvic flexure in ponies: effects of six drugs. American Journal of Veterinary Research 1984, 45:795-799.
3. Andrews F, Jenkins C, Frazier D, et al. The effect of oral omeprazole on basal and pentagastrin-stimulated gastric secretion in young female horses. Equine Veterinary Journal Supplement 1992, 13:80-83.
4. Andrews FM, Sifferman RL, Bernard W, et al. Efficacy of omeprazole paste in the treatment and prevention of gastric ulcers in horses. Equine Veterinary Journal Supplement 1999, 29:81-86.
5. Argenzio RA, Stevens CE Cyclic changes in ionic composition of digesta in the equine intestinal tract. American Journal of Physiology 1975, 228:1224-1230.
6. Barone JA Domperidone: a peripherally acting dopamine 2-receptor antagonist. Annals of Pharmacotherapy 1999, 33:429-440.
7. Bellissant E, Duhamel JF, Guillot M, et al. The triangular test to assess the efficacy of metoclopramide in gastroesophageal reflux. Clinical Pharmacology and Therapeutics 1997, 61:377-384.
8. Besancon M, Simon A, Sachs G, et al. Sites of reaction of the gastric H +, K +-ATPase with extracytoplasmic thiol reagents. Journal of Biological Chemistry 1997, 272:22438-22446.
9. Botella A, Vabre F, Fioramonti J, et al. In vivo inhibitory effect of lanreotide (BIM 23014), a new somatostatin analog, on prostaglandin- and cholera toxin-stimulated intestinal fluid in the rat. Peptides 1993, 14:297-301.
10. Brzozowski T, Konturek SJ, Sliwowski Z, et al. Role of L-arginine, a substrate for NO-synthase, in gastroprotection and ulcer healing. Journal of Gastroenterology 1997, 32:442-452.
11. Camilleri M Tegaserod. Alimentary Pharmacology and Therapeutics 2001, 15:277-289.
12. Campbell-Thompson ML, Merritt AM Effect of ranitidine on gastric acid secretion in young male horses. American Journal of Veterinary Research 1987, 48:1511-1515.
13. Campbell-Thompson ML, Merritt AM Basal and pentagastrin-stimulated gastric secretion in young horses. American Journal of Physiology 1990, 259:R1259-R1266.
14. Cederberg C, Andersson T, Skanberg I, Omeprazole: pharmacokinetics and metabolism in man. Scandinavian Journal of Gastroenterology Supplement 1989, 166:33-42.
15. Clark CK, Merritt AM, Burrow JA, et al. Effect of an aluminum-magnesium hydroxide antacid and BSS on gastric pH in horses. Journal of the American Veterinary Medical Association 1996, 208:1687-1691.
16. Clarke LL, Argenzio RA, Roberts MC Effect of meal feeding on plasma volume and urinary electrolyte clearance in ponies. American Journal of Veterinary Research 1990, 51:571-576.
17. Collins LG, Tyler DE Experimentally induced phenylbutazone toxicosis in ponies: description of the syndrome and its prevention with synthetic prostaglandin E 2. American Journal of Veterinary Research 1985, 46:1605-1615.
18. Cook G, Papich MG, Roberts MC, et al. Pharmacokinetics of cisapride in horses after intravenous and rectal administration. American Journal of Veterinary Research 1997, 58:1427-1430.
19. Dabareiner RM, Snyder JR, White NA, et al. Microvascular permeability and endothelial cell morphology associated with low-flow ischemia/reperfusion injury in the equine jejunum. American Journal of Veterinary Research 1995, 56:639-648.
20. Dajani EZ, Agrawal NM Protective effects of prostaglandins against nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. International Journal of Clinical Pharmacology Research 1989, 9:359-369.
21. Dart AJ, Peauroi JR, Hodgson DR, et al. Efficacy of metoclopramide for treatment of ileus in horses following small intestinal surgery: 70 cases (1989-1992). Australian Veterinary Journal 1996, 74:280-284.
22. Daurio CP, Holste JE, Andrews FM, et al. Effect of omeprazole paste on gastric acid secretion in horses. Equine Veterinary Journal Supplement 1999, 29:59-62.
23. de Boer RE, Brouwer F, Zaagsma J The beta adrenoceptors mediating relaxation of rat oesophageal muscularis mucosae are predominantly of the beta 3- but also of the beta 2-subtype. British Journal of Pharmacology 1993, 110:442-446.
24. Degen L, Matzinger D, Merz M, et al. Tegaserod, a 5-HT 4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Alimentary Pharmacology and Therapeutics 2001, 15:1745-1751.
25. De Luca A, Coupar IM Insights into opioid action in the intestinal tract. Pharmacology and Therapeutics 1996, 69:103-115.
26. De Ponti F, Giaroni C, Cosentino M, et al. Adrenergic mechanisms in the control of gastrointestinal motility: from basic science to clinical applications. Pharmacology and Therapeutics 1996, 69:59-78.
27. Der-Silaphet T, Malysz J, Hagel S, et al. Interstitial cells of Cajal direct normal propulsive contractile activity in the mouse small intestine. Gastroenterology 1998, 114:724-736.
28. Dobbins J, Racusen L, Binder HJ Effect of D-alanine methionine enkephalin amide on ion transport in rabbit ileum. Journal of Clinical Investigation 1980, 66:19-28.
29. Doherty TJ, Andrews FM, Abraha TW, et al. Metoclopramide ameliorates the effects of endotoxin on gastric emptying of acetaminophen in horses. Canadian Journal of Veterinary Research 1999, 63:37-40.
30. Duran SH, Ravis WR 1993, Comparative pharmacokinetics of H2 antagonists in horses. In: Proceedings of the 11th American College of Veterinary Internal Medicine Forum, Washington, DC, pp. 687-690.
31. Duval-lflah Y, Berard H, Baumer P, et al. Effects of racecadotril and loperamide on bacterial proliferation and on the central nervous system of the newborn gnotobiotic piglet. Alimentary Pharmacology and Therapeutics 1999, 13(suppl 6):9-14.
32. Dwinell MB, Eckmann L, Leopard JD, et al. Chemokine receptor expression by human intestinal epithelial cells. Gastroenterology 1999, 117:359-367.
33. Eades SC, Moore JN Blockade of endotoxin-induced cecal hypoperfusion and ileus with an alpha 2 antagonist in horses. American Journal of Veterinary Research 1993, 54:586-590.
34. Eberhart CE, Dubois RN Eicosanoids and the gastrointestinal tract. Gastroenterology 1995, 109:285-301.
35. Ennes HS, Young SH, Raybould HE, et al. Intercellular communication between dorsal root ganglion cells and colonic smooth muscle cells in vitro. Neuroreport 1997, 8:733-737.
36. Ericsson CD, Feldman S, Pickering LK, et al. Influence of subsalicylate bismuth on absorption of doxycycline. Journal of the American Medical Association 1982, 247:2266-2267.
37. Ericsson CD, Tannenbaum C, Charles TT Antisecretory and antiinflammatory properties of bismuth subsalicylate. Reviews of Infectious Diseases 1990, 12(suppl 1):S16-S20.
38. Figueroa-Quintanilla D, Salazar-Lindo E, Sack RB, et al. A controlled trial of bismuth subsalicylate in infants with acute watery diarrheal disease. New England Journal of Medicine 1993, 328:1653-1658.
39. Fine KD, Lee EL Efficacy of open-label bismuth subsalicylate for the treatment of microscopic colitis. Gastroenterology 1998, 114:29-36.
40. Freeman DE, Ferrante PL, Palmer JE Comparison of the effects of intragastric infusions of equal volumes of water, dioctyl sodium sulfosuccinate and magnesium sulfate on fecal composition and output in clinically normal horses. American Journal of Veterinary Research 1992, 53:1347-1353.
41. Furr MO, Murray MJ Treatment of gastric ulcers in horses with histamine type 2 receptor antagonists. Equine Veterinary Journal Supplement 1989, 7:77-79.
42. Gemmell CG Comparative study of the nature and biological activities of bacterial enterotoxins. Journal of Medical Microbiology 1984, 17:217-235.
43. Gerloff J, Mignot A, Barth H, et al. Pharmacokinetics and absolute bioavailability of lansoprazole. European Journal of Clinical Pharmacology 1996, 50:293-297.
44. Gerring EL, Hunt JM Pathophysiology of equine postoperative ileus: effect of adrenergic blockade, parasympathetic stimulation and metoclopramide in an experimental model. Equine Veterinary Journal 1986, 18:249-255.
45. Gerring EL, King JN Cisapride in the prophylaxis of equine post operative ileus. Equine Veterinary Journal Supplement 1989, 7:52-55.
46. Giaroni C, De Ponti F, Cosentino M, et al. Plasticity in the enteric nervous system. Gastroenterology 1999, 117:1438-1458.
47. Grande L, Lacima G, Ros E, et al. Lack of effect of metoclopramide and domperidone on esophageal peristalsis and esophageal acid clearance in reflux esophagitis. A randomized, double-blind study. Digestive Diseases and Sciences 1992, 37:583-588.
48. Hammock PD, Freeman DE, Baker GJ Failure of psyllium mucilloid to hasten evaluation of sand from the equine large intestine. Veterinary Surgery 1998, 27:547-554.
49. Hance SR, Noble J, Holcomb S, et al. 1997, Treating choke with oxytocin. In: Proceedings of the 43rd American Association of Equine Practitioners Annual Convention, Phoenix, AZ, pp. 338-339.
50. Haven ML, Dave K, Burrow JA, et al. Comparison of the antisecretory effects of omeprazole when administered intravenously, as acid-stable granules and as an oral paste in horses. Equine Veterinary Journal Supplement 1999, 29:54-58.
51. Hawkey CJ, Karrasch JA, Szczepanski L, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. New England Journal of Medicine 1998, 338:727-734.
52. Henninger RW, Horst J Magnesium toxicosis in two horses. Journal of the American Veterinary Medical Association 1997, 211:82-85.
53. Hojgaard L, Mertz Nielsen A, Rune SJ Peptic ulcer pathophysiology: acid, bicarbonate and mucosal function. Scandinavian Journal of Gastroenterology Supplement 1996, 216:10-15.
54. Holland RE, Sriranganathan N, DuPont L Isolation of enterotoxigenic Escherichia coli from a foal with diarrhea. Journal of the American Veterinary Medical Association 1989, 194:389-391.
55. Holzer P Neural emergency system in the stomach. Gastroenterology 1998, 114:823-839.
56. Huber R, Hartmann M, Bliesath H, et al. Pharmacokinetics of pantoprazole in man. International Journal of Clinical Pharmacology and Therapeutics 1996, 34(supp M):S7-S16.
57. Izzo AA, Mascolo N, Capasso F NO as a modulator of intestinal water and electrolyte transport. Digestive Diseases and Sciences 1998, 43:1605-1620.
58. Jenkins C, Frazier D, Blackford J, et al. Duration of anti-secretory effects of omeprazole in horses with chronic gastric cannulae. Equine Veterinary Journal Supplement 1992, 13:89-92.
59. Jenkins CC, Frazier DL, Blackford JT, et al. Pharmacokinetics and anti-secretory effects of intravenous omeprazole in horses. Equine Veterinary Journal Supplement 1992, 13:84-88.
60. Johnson CM, Cullen JM, Roberts MC Morphologic characterization of castor oil-induced colitis in ponies. Veterinary Pathology 1993, 30:248-255.
61. Kalff JC, Schraut WH, Simmons RL, et al. Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileus. Annals of Surgery 1998, 228:652-663.
62. Kalff JC, Carlos TM, Schraut WH, et al. Surgically induced leukocytic infiltrates within the rat intestinal muscularis mediate postoperative ileus. Gastroenterology 1999, 117:378-387.
63. Kalff JC, Schraut WH, Billiar TR, et al. Role of inducible NO synthase in postoperative intestinal smooth muscle dysfunction in rodents. Gastroenterology 2000, 118:316-327.
64. Kamerling SG, Hamra JG, Bagwell CA Naloxone-induced abdominal distress in the horse. Equine Veterinary Journal 1990, 22:241-243.
65. Katschinski M, Steinicke C, Reinshagen M, et al. Gastrointestinal motor and secretory responses to cholinergic stimulation in humans. Differential modulation by muscarinic and cholecystokinin receptor blockade. European Journal of Clinical Investigation 1995, 25:113-122.
66. Katz J Acid secretion and suppression. Medical Clinics of North America 1991, 75:877-887.
67. King JN, Gerring EL Actions of the novel gastrointestinal prokinetic agent cisapride on equine bowel motility. Journal of Veterinary Pharmacology and Therapeutics 1988, 11:314-321.
68. King JN, Davies JV, Gerring EL Contrast radiography of the equine oesophagus: effect of spasmolytic agents and passage of a nasogastric tube. Equine Veterinary Journal 1990, 22:133-135.
69. Kitchen DL, Merritt AM, Burrow JA Histamine-induced gastric acid secretion in horses. American Journal of Veterinary Research 1998, 59:1303-1306.
70. Kitchen DL, Merritt AM, Burrow JA, et al. 1998b, Source of non-parietal component of pentagastrin-stimulated fasting equine gastric contents. In: Proceedings of the 6th Equine Colic Research Symposium, Athens, GA, p. 35.
71. Konturek SJ, Brzozowski T, Majka J, et al. NO in gastroprotection by aluminum-containing antacids. European Journal of Pharmacology 1992, 229:155-162.
72. Krejs GJ Physiological role of somatostatin in the digestive tract: gastric acid secretion, intestinal absorption and motility. Scandinavian Journal of Gastroenterology Supplement 1986, 119:47-53.
73. Lester GD, Merritt AM, Neuwirth L, et al. Effect of alpha 2 adrenergic, cholinergic and nonsteroidal anti-inflammatory drugs on myoelectric activity of ileum, cecum and right ventral colon and on cecal emptying of radiolabeled markers in clinically normal ponies. American Journal of Veterinary Research 1998, 59:320-327.
74. Lester GD, Merritt AM, Neuwirth L, et al. Effect of erythromycin lactobionate on myoelectric activity of ileum, cecum and right ventral colon and cecal emptying of radiolabeled markers in clinically normal ponies. American Journal of Veterinary Research 1998, 59:328-334.
75. Lippold BS, Weiss R, Mevissen M, et al. 2002, The properties of a new promotile drug, tegaserod (HTF 919) in equines. In: Proceedings of the 7th International Equine Colic Research Symposium, Birmingham, UK, p. 46.
76. Longo WE, Vernava AMD Prokinetic agents for lower gastrointestinal motility disorders. Diseases of the Colon and Rectum 1993, 36:696-708.
77. Lowe JE, Sellers AF, Brondum J Equine pelvic flexure impaction. A model used to evaluate motor events and compare drug response. Cornell Veterinarian 1980, 70:401-412.
78. Lyrenas E Beta adrenergic influence on esophageal and colonic motility in man. Scandinavian Journal of Gastroenterology Supplement 1985, 116:1-48.
79. MacAllister CG, Lowrey F, Stebbins M, et al. Transendoscopic electrocautery-induced gastric ulcers as a model for gastric healing studies in ponies. Equine Veterinary Journal 1994, 26:100-103.
80. MacAllister CG, Sangiah S Effect of ranitidine on healing of experimentally induced gastric ulcers in ponies. American Journal of Veterinary Research 1993, 54:1103-1107.
81. MacDonald TM Metoclopramide, domperidone and dopamine in man: actions and interactions. European Journal of Clinical Pharmacology 1991, 40:225-230.
82. Madigan JE Disorders of the first two weeks of Age. Manual of equine neonatal medicine 1997, 119. Live Oak Publishing, Woodland, CA. 3rd edn. J.E. Madigan (Ed.).
83. Malone ED, Brown DR, Trent AM, et al. Influence of adrenergic and cholinergic mediators on the equine jejunum in vitro. American Journal of Veterinary Research 1996, 57:884-890.
84. Malone ED, Turner TA, Wilson JH 1998, Intravenous lidocaine for the treatment of equine ileus. In: Proceedings of the 6th Equine Colic Research Symposium, Athens, GA, p. 42.
85. Matheson AJ, Noble S Racecadotril. Drugs 2000, 59:829-837.
86. Mathews CJ, MacLeod RJ, Zheng SX, et al. Characterization of the inhibitory effect of boiled rice on intestinal chloride secretion in guinea pig crypt cells. Gastroenterology 1999, 116:1342-1347.
87. McCallum RW Pharmacologic modulation of motility. Yale Journal of Biology and Medicine 1999, 72:173-180.
88. McCarthy DM Sucralfate. New England Journal of Medicine 1991, 325:1017-1025.
89. Merritt AM Normal equine gastroduodenal secretion and motility. Equine Veterinary Journal Supplement 1999, 29:7-13.
90. Merritt AM, Burrow JA, Horbal MJ, et al. Effect of omeprazole on sodium and potassium output in pentagastrin-stimulated equine gastric contents. American Journal of Veterinary Research 1996, 57:1640-1644.
91. Merritt AM, Burrow JA, Hartless CS Effect of xylazine, detomidine and a combination of xylazine and butorphanol on equine duodenal motility. American Journal of Veterinary Research 1998, 59:619-623.
92. Merritt AM, Campbell-Thompson ML, Lowrey S Effect of xylazine treatment on equine proximal gastrointestinal tract myoelectrical activity. American Journal of Veterinary Research 1989, 50:945-949.
93. Merritt AM, Sanchez LS, Burrow JA, et al. 2002, Bioavailability of "Gastrogard ™" vs. three generic compounded omeprazole preparations in mature horses. In: Proceedings of the 7th International Equine Colic Research Symposium, Birmingham, UK, p. 81.
94. Meyer GA, Rashmir-Raven A, Helms RJ, et al. The effect of oxytocin on contractility of the equine oesophagus: a potential treatment for oesophageal obstruction. Equine Veterinary Journal 2000, 32:151-155.
95. Mullersman G, Gotz VP, Russell WL, Derendorf H Lack of clinically significant in vitro and in vivo interactions between ranitidine and sucralfate. Journal of Pharmaceutical Sciences 1986, 75:995-998.
96. Murray MJ, Eichorn ES Effects of intermittent feed deprivation, intermittent feed deprivation with ranitidine administration and stall confinement with ad libitum access to hay on gastric ulceration in horses. American Journal of Veterinary Research 1996, 57:1599-1603.
97. Murray MJ, Grodinsky C The effects of famotidine, ranitidine and magnesium hydroxide/aluminum hydroxide on gastric fluid pH in adult horses. Equine Veterinary Journal Supplement 1992, 11:52-55.
98. Murray MJ, Nout YS, Ward DL Endoscopic findings of the gastric antrum and pylorus in horses: 162 cases (1996-2000). Journal of Veterinary Internal Medicine 2001, 14:401-406.
99. Murray MJ, Schusser GF Measurement of 24-h gastric pH using an indwelling pH electrode in horses unfed, fed and treated with ranitidine. Equine Veterinary Journal 1993, 25:417-421.
100. Ness TJ Kappa opioid receptor agonists differentially inhibit two classes of rat spinal neurons excited by colorectal distention. Gastroenterology 1999, 117:388-394.
101. Nguyen A, Camilleri M, Kost LJ, et al. SDZ HTF 919 stimulates canine colonic motility and transit in vivo. Journal of Pharmacology and Experimental Therapeutics 1997, 280:1270-1276.
102. Nieto JE, Spier SJ, van Hoogmoed L, et al. Comparison of omeprazole and cimetidine in healing of gastric ulcers and prevention of recurrence in horses. Equine Veterinary Education 2001, 13:260-264.
103. Nwokolo CU, Mistry P, Pounder RE The absorption of bismuth and salicylate from oral doses of Pepto-Bismol (bismuth salicylate). Alimentary Pharmacology and Therapeutics 1990, 4:163-169.
104. Rabon EC, Reuben MA The mechanism and structure of the gastric H +, K +-ATPase. Annual Review of Physiology 1990, 52:321-344.
105. Redmond LM, Cross DL, Strickland JR, et al. Efficacy of domperidone and sulpiride as treatments for fescue toxicosis in horses. American Journal of Veterinary Research 1994, 55:722-729.
106. Rhoads WS, Barton MH, Parks AH Comparison of medical and surgical treatment for impaction of the small colon in horses: 84 cases (1986-1996). Journal of the American Veterinary Medical Association 1999, 214:1042-1047.
107. Richards WG, Sugarbaker DJ Neuronal control of esophageal function. Chest Surgery Clinics of North America 1995, 5:157-171.
108. Rimback G, Cassuto J, Tollesson PO Treatment of postoperative paralytic ileus by intravenous lidocaine infusion. Anesthesia and Analgesia 1990, 70:414-419.
109. Ringger NC, Lester GD, Neuwirth L, et al. Effect of bethanechol or erythromycin on gastric emptying in horses. American Journal of Veterinary Research 1996, 57:1771-1775.
110. Roberts MC, Clarke LL, Johnson CM Castor-oil induced diarrhoea in ponies: a model for acute colitis. Equine Veterinary Journal Supplement 1989, 7:60-67.
111. Roelvink ME, Goossens L, Kalsbeek HC, et al. Analgesic and spasmolytic effects of dipyrone, hyoscine- N-butylbromide and a combination of the two in ponies. Veterinary Record 1991, 129:378-380.
112. Roger T, Bardon T, Ruckebusch Y Colonic motor responses in the pony: relevance of colonic stimulation by opiate antagonists. American Journal of Veterinary Research 1985, 46:31-35.
113. Roger T, Ruckebusch Y Pharmacological modulation of postprandial colonic motor activity in the pony. Journal of Veterinary Pharmacology and Therapeutics 1987, 10:273-282.
114. Roth SH Misoprostol in the prevention of NSAID-induced gastric ulcer: a multicenter, double-blind, placebo-controlled trial. Journal of Rheumatology Supplement 1990, 20:20-24.
115. Ruppin H Loperamide: a potent antidiarrhoeal drug with actions along the alimentary tract. Alimentary Pharmacology and Therapeutics 1987, 1:179-190.
116. Rutkowski JA, Eades SC, Moore JN Effects of xylazine butorphanol on cecal arterial blood flow, cecal mechanical activity and systemic hemodynamics in horses. American Journal of Veterinary Research 1991, 52:1153-1158.
117. Sams RA, Gerken DF, Dyke TM, et al. Pharmacokinetics of intravenous and intragastric cimetidine in horses. I. Effects of intravenous cimetidine on pharmacokinetics of intravenous phenylbutazone. Journal of Veterinary Pharmacology and Therapeutics 1997, 20:355-361.
118. Sanchez LC, Lester GD, Merritt AM Effect of ranitidine on intragastric pH in clinically normal neonatal foals. Journal of the American Veterinary Medical Association 1998, 212:1407-1412.
119. Sandin A, Andrews FM, Nadeau JA, et al. Effects of intramuscular omeprazole on gastric acid secretion in horses over a twenty-four hour period. Equine Veterinary Journal Supplement 1999, 29:50-53.
120. Sandin A, Andrews FM, Nadeau JA, et al. Effect of nervous excitation on acid secretion in horses. Acta Physiologica Scandinavica 2000, 168:437-442.
121. Sangiah S, MacAllister CC, Amouzadeh HR Effects of cimetidine and ranitidine on basal gastric pH, free and total acid contents in horses. Research in Veterinary Science 1988, 45:291-295.
122. Sangiah S, MacAllister CC, Amouzadeh HR Effects of misoprostol and omeprazole on basal gastric pH and free acid content in horses. Research in Veterinary Science 1989, 47:350-354.
123. Scarff KL, Judd LM, Toh BH, et al. Gastric H(+), K(+)-adenosine triphosphatase beta subunit is required for normal function, development and membrane structure of mouse parietal cells. Gastroenterology 1999, 117:605-618.
124. Schoenfeld P, Kimmey MB, Scheiman J, et al. Nonsteroidal anti-inflammatory drug-associated gastrointestinal complications: guidelines for prevention and treatment. Alimentary Pharmacology and Therapeutics 1999, 13:1273-1285.
125. Schumacher J, DeGraves FJ, Spano JS Clinical and clinicopathologic effects of large doses of raw linseed oil as compared to mineral oil in healthy horses. Journal of Veterinary Internal Medicine 1997, 11:296-299.
126. Schusser GE, White NA Morphologic and quantitative evaluation of the myenteric plexuses and neurons in the large colon of horses. Journal of the American Veterinary Medical Association 1997, 210:928-934.
127. Sellers AF, Lowe JE, Rendano VT, et al. The reservoir function of the equine cecum and ventral large colon: its relation to chronic non-surgical obstructive disease with colic. Cornell Veterinarian 1982, 72:233-241.
128. Sjoqvist A, Hallerback B, Glise H Reflex adrenergic inhibition of colonic motility in anesthetized rat caused by nociceptive stimuli of peritoneum, Digestive Diseases and Sciences 1985, 30:749-754.
129. Smyth GB, Duran S, Ravis W, et al. Pharmacokinetic studies of cimetidine hydrochloride in adult horses. Equine Veterinary Journal 1990, 22:48-50.
130. Sojka JE, Adams SB, Lamar CH, et al. Effect of butorphanol, pentazocine, meperidine, or metoclopramide on intestinal motility in female ponies. American Journal of Veterinary Research 1988, 49:527-529.
131. Sojka JE, Weiss JS, Samuels ML, et al. Effect of the somatostatin analog octreotide on gastric fluid pH in ponies. American Journal of Veterinary Research 1992, 53:1818-1821.
132. Sondheimer JM, Arnold GL Early effects of bethanechol on the esophageal motor function of infants with gastroesophageal reflux. Journal of Pediatric Gastroenterology and Nutrition 1986, 5:47-51.
133. Steel CM, Bolton JR, Preechagoon Y, et al. Pharmacokinetics of cisapride in the horse. Journal of Veterinary Pharmacology and Therapeutics 1998, 21:433-436.
134. Steel CM, Bolton JR, Preechagoon Y, et al. Unreliable rectal absorption of cisapride in horses. Equine Veterinary Journal 1999, 31:82-84.
135. Thillainayagam AV, Hunt JB, Farthing MJ Enhancing clinical efficacy of oral rehydration therapy: is low osmolality the key?. Gastroenterology 1998, 114:197-210.
136. Thompson LP, Burrow JA, Madison JR, et al. 1994, Effect of bethanechol on equine gastric motility and secretion. In: Proceedings of the 5th Equine Colic Research Symposium, Athens, GA, p. 12.
137. Tillman LA, Drake FM, Dixon JS, et al. Safety of bismuth in the treatment of gastrointestinal diseases. Alimentary Pharmacology and Therapeutics 1996, 10:459-467.
138. Tonini M Recent advances in the pharmacology of gastrointestinal prokinetics. Pharmacological Research 1996, 33:217-226.
139. Udassin R, Eimerl D, Schiffman J, et al. Epidural anesthesia accelerates the recovery of postischemic bowel motility in the rat. Anesthesiology 1994, 80:832-836.
140. Valk N, Doherty TJ, Blackford JT, et al. Effect of cisapride on gastric emptying in horses following endotoxin treatment. Equine Veterinary Journal 1998, 30:344-348.
141. Vitola JV, Forman MB, Holsinger JP, et al. Reduction of myocardial infarct size in rabbits and inhibition of activation of rabbit and human neutrophils by lidocaine. American Heart Journal 1997, 133:315-322.
142. Washabau RJ, Hall JA Cisapride. Journal of the American Veterinary Medical Association 1995, 207:1285-1288.
143. Watson TD, Sullivan M Effects of detomidine on equine oesophageal function as studied by contrast radiography. Veterinary Record 1991, 129:67-69.
144. Zhao XT, Wang L, Lin HC Slowing of intestinal transit by fat depends on naloxone-blockable efferent, opioid pathway. American Journal of Physiology: Gastrointestinal and Liver Physiology 2000, 278:G866-G870.